Quelltext anzeigen

{{tp|p=32284245|t=ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??|pdf=|usr=}}
{{tp|p=32366317|t=2020. Covid-19 The real role of NSAIDs in Italy |pdf=|usr=}}
{{tp|p=32360482|t=2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?|pdf=|usr=}}
{{tp|p=32321720|t=2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) |pdf=|usr=}}
{{tp|p=32234728|t=2020. EMA advice on the use of NSAIDs for Covid-19 |pdf=|usr=}}
{{tp|p=32220865|t=2020. Non-steroidal anti-inflammatory drugs and covid-19 |pdf=|usr=}}
{{tp|p=32205306|t=2020. Covid-19: European drugs agency to review safety of ibuprofen |pdf=|usr=}}
{{tp|p=32184201|t=2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists |pdf=|usr=}}
{{tp|p=32253225|t=2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected  cases |pdf=|usr=}}
{{tp|p=C7149289|t=2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19 |pdf=|usr=}}
{{tp|p=32435882|t=2020. Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.|pdf=|usr=008}}
{{tp|p=32460369|t=2020. Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence.|pdf=|usr=008}}
{{tp|p=32412158|t=2020. Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.|pdf=|usr=008}}
{{tp|p=32303505|t=2020. Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear.|pdf=|usr=007}}
{{tp|p=32530870|t=2020. Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections.|pdf=|usr=011}}